Senseonics (SENS) Competitors $0.46 -0.01 (-1.60%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$0.47 +0.01 (+2.62%) As of 06:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SENS vs. TXG, EYPT, AEHR, ALNT, TRNS, LAB, CTKB, FEIM, MASS, and QSIShould you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Allient (ALNT), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), 908 Devices (MASS), and Quantum-Si (QSI). These companies are all part of the "measuring and control equipment" industry. Senseonics vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Aehr Test Systems Allient Transcat Standard BioTools Cytek Biosciences Frequency Electronics 908 Devices Quantum-Si 10x Genomics (NASDAQ:TXG) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends. Which has more risk & volatility, TXG or SENS? 10x Genomics has a beta of 2.05, meaning that its stock price is 105% more volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Do institutionals and insiders have more ownership in TXG or SENS? 84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 3.6% of Senseonics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation & earnings, TXG or SENS? Senseonics has lower revenue, but higher earnings than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.46-$182.63M-$0.70-17.24Senseonics$25.47M14.78-$60.39M-$0.10-4.62 Does the media prefer TXG or SENS? In the previous week, Senseonics had 1 more articles in the media than 10x Genomics. MarketBeat recorded 6 mentions for Senseonics and 5 mentions for 10x Genomics. 10x Genomics' average media sentiment score of 0.69 beat Senseonics' score of 0.16 indicating that 10x Genomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Senseonics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend TXG or SENS? 10x Genomics presently has a consensus price target of $13.65, indicating a potential upside of 13.12%. Senseonics has a consensus price target of $1.54, indicating a potential upside of 232.86%. Given Senseonics' stronger consensus rating and higher possible upside, analysts plainly believe Senseonics is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 2 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.25Senseonics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Is TXG or SENS more profitable? 10x Genomics has a net margin of -13.13% compared to Senseonics' net margin of -362.30%. 10x Genomics' return on equity of -12.88% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Senseonics -362.30%-842.25%-67.99% Summary10x Genomics beats Senseonics on 9 of the 17 factors compared between the two stocks. Get Senseonics News Delivered to You Automatically Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SENS vs. The Competition Export to ExcelMetricSenseonicsProcess control instruments IndustryMedical SectorNYSE ExchangeMarket Cap$376.30M$188.18M$6.09B$22.02BDividend YieldN/AN/A5.69%3.58%P/E Ratio-3.55N/A85.5529.86Price / Sales14.787.39537.7964.52Price / CashN/AN/A37.9224.43Price / Book6.606.6012.994.64Net Income-$60.39M-$31.84M$3.30B$1.01B7 Day Performance5.94%5.94%4.33%0.44%1 Month Performance4.03%4.03%9.48%3.13%1 Year Performance35.85%35.85%84.61%15.30% Senseonics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SENSSenseonics2.3256 of 5 stars$0.46-1.6%$1.54+232.9%+37.5%$376.30M$25.47M-3.5590News CoverageGap UpTXG10x Genomics3.7949 of 5 stars$11.34-3.2%$13.65+20.4%-40.0%$1.41B$644.47M-16.201,240EYPTEyepoint Pharmaceuticals1.1875 of 5 stars$14.05+1.1%$26.86+91.2%+63.7%$968.47M$43.27M-5.24120News CoveragePositive NewsAnalyst ForecastAEHRAehr Test Systems1.6449 of 5 stars$30.45+0.9%N/A+106.0%$912.59M$58.97M-234.2190Trending NewsEarnings ReportAnalyst DowngradeGap UpALNTAllient2.6403 of 5 stars$43.28-1.2%$35.00-19.1%+152.4%$733.60M$529.97M50.332,525Positive NewsAnalyst ForecastTRNSTranscat3.1779 of 5 stars$72.73-1.3%$112.20+54.3%-40.6%$677.84M$278.42M50.861,245Analyst ForecastLABStandard BioTools2.2009 of 5 stars$1.27-2.3%$1.55+22.0%-26.7%$485.13M$174.43M-3.97620News CoveragePositive NewsAnalyst ForecastCTKBCytek Biosciences2.4575 of 5 stars$3.38-0.6%$5.60+65.7%-22.6%$430.00M$200.45M-67.60500News CoveragePositive NewsAnalyst UpgradeFEIMFrequency Electronics1.8319 of 5 stars$32.09+6.6%$43.00+34.0%+215.3%$312.88M$69.81M14.01200Analyst ForecastMASS908 Devices1.8473 of 5 stars$8.15+1.7%$8.00-1.8%+162.9%$292.26M$59.63M-15.0960Analyst ForecastQSIQuantum-Si2.5098 of 5 stars$1.39-6.7%$3.48+150.0%+111.4%$281.47M$3.41M-2.04150Analyst ForecastGap Down Related Companies and Tools Related Companies TXG Alternatives EYPT Alternatives AEHR Alternatives ALNT Alternatives TRNS Alternatives LAB Alternatives CTKB Alternatives FEIM Alternatives MASS Alternatives QSI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SENS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
